Indivior Pharmaceuticals, Inc. INDV
NASDAQ · United States · Health Technology
$35.85-0.74 (-2.02%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | 1.15 | 0.87 | +32.3% | $343.00M | +12.0% | -8.8%$40.01→$36.50 |
| Q1 2026 | 2026-04-30 | 0.96 | 0.64 | +50.0% | — | — | +10.3%$34.15→$37.66 |
| Q4 2025 | 2026-02-26 | 0.82 | 0.65 | +26.2% | — | — | -2.7%$33.63→$32.72 |
| Q3 2025 | 2025-10-30 | 0.72 | 0.38 | +89.5% | — | — | +16.4%$25.24→$29.37 |
| Q1 2025 | 2025-04-24 | 0.41 | 0.23 | +78.3% | — | — | — |
| Q4 2024 | 2025-02-20 | 0.32 | 0.26 | +23.1% | — | — | — |
| Q3 2024 | 2024-10-24 | 0.54 | 0.41 | +31.7% | — | — | — |
| Q2 2024 | 2024-07-25 | 0.44 | 0.40 | +10.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.